Our findings revealed no significant differences in PD-1+CD4+T/ CD4+T% and PD-1+CD8+T/ CD8+T% among individuals experiencing AECOPD re-admission, regardless of the presence of concurrent pulmonary hypertension (PH)(Figure 2A, B). The gene discussed is CD4; the disease is pulmonary hypertension.